NDC 73591-5886-01 - LEDERLE LEUCOVORIN
This NDC is not currently matched to an FDA NDC product listing in FDA.report, but it is a valid NDC-form code. FDA.report is showing the available DailyMed label context for the product root.
- Product NDC
- 73591-5886
- Requested NDC
- 73591-5886-01
- Package NDCs from labels
- 73591-5886-2, 73591-5886-1, 73591-5886-01
- Manufacturer
- FARMASIERRA MANUFACTURING SL | HOSPIRA WORLDWIDE, LLC
- Effective date
- 2025-11-24
- Current FDA listing
- Not matched in FDA.report NDC product tables
DailyMed Labels#
| Label | Manufacturer | Effective date | Type |
|---|---|---|---|
| LEDERLE LEUCOVORIN - FARMASIERRA MANUFACTURING SL | HOSPIRA WORLDWIDE, LLC | FARMASIERRA MANUFACTURING SL | HOSPIRA WORLDWIDE, LLC | 2025-11-24 | HUMAN PRESCRIPTION DRUG LABEL |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 73591-5886-1 | LEDERLE LEUCOVORIN | 100 in 1 BOTTLE, PLASTIC | TABLET | 100 | 1 | |
| 73591-5886-2 | LEDERLE LEUCOVORIN | 24 in 1 BOTTLE, PLASTIC | TABLET | 24 | 1 |
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Leucovorin Calcium | LEUCOVORIN CALCIUM | American Health Packaging | f7004cbd-9827-466e-9683-adce4f13c6a6 | 2026-07-01 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Sagent Pharmaceuticals | c0cbcbf6-6fd2-4cf3-877a-bb0fe3df4e59 | 2026-06-16 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Teva Pharmaceuticals USA, Inc. | 94669fc8-3c1c-4228-be27-09a1cd468c36 | 2026-03-31 | Warnings, Adverse reactions | 197863 RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Major Pharmaceuticals | 273407f5-0be2-435a-b7a8-f21be8ffbb3c | 2026-03-27 | Warnings, Adverse reactions | RPR1R4C0P4 |
| LEUCOVORIN CALCIUM | LEUCOVORIN CALCIUM | Leading Pharma, LLC | c8102043-79f2-421a-b849-94bac19007a6 | 2026-03-27 | Warnings, Adverse reactions | 197863 RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Ingenus Pharmaceuticals, LLC | 7409cdee-9093-47af-a4c4-2c55ce1b6361 | 2026-03-18 | Warnings, Adverse reactions | 197863 RPR1R4C0P4 |
| VYKOURA | LEUCOVORIN CALCIUM | Avyxa Pharma, LLC | d122b875-435e-4e00-b945-7a0546df95c2 | 2026-03-12 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Sagent Pharmaceuticals | 9d0e5356-ff39-4a8e-944c-e808a21ef4b2 | 2026-03-11 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Hikma Pharmaceuticals USA Inc. | 33663425-4731-4977-9127-9e59b6b91497 | 2026-03-10 | Warnings, Adverse reactions | 197863 RPR1R4C0P4 |
| LEDERLE LEUCOVORIN | CALCIUM FOLINATE | Pfizer Laboratories Div Pfizer Inc | 4734ce39-440d-4a8f-8613-2905408b42cd | 2025-12-18 | 197863 RPR1R4C0P4 | |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | GLENMARK PHARMACEUTICALS INC., USA | 79d023ab-7d77-48c1-8f47-ea322fd58c2b | 2025-12-09 | Warnings, Adverse reactions | RPR1R4C0P4 |
| LEDERLE LEUCOVORIN | CALCIUM FOLINATE | FARMASIERRA MANUFACTURING SL | 4457d4e3-5942-1a73-e063-6394a90abb24 | 2025-11-24 | 73591-5886-1 73591-5886-2 73591-5886 73591588601 197863 4457d4e3-5943-1a73-e063-6394a90abb24 4457d4e3-5942-1a73-e063-6394a90abb24 RPR1R4C0P4 | |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Gland Pharma Limited | 968b192b-72f3-41b0-a1f5-bab8a96d3419 | 2025-11-13 | Warnings, Adverse reactions | RPR1R4C0P4 |
| leucovorin calcium | LEUCOVORIN CALCIUM | BluePoint Laboratories | f579879c-7d53-4663-8ad8-84b8b645cda5 | 2025-09-29 | Warnings, Adverse reactions | RPR1R4C0P4 |
| leucovorin calcium | LEUCOVORIN CALCIUM | Meitheal Pharmaceuticals Inc. | 9df20901-6980-4d4e-89ec-40f3c1f91852 | 2025-03-19 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Slate Run Pharmaceuticals, LLC | d8bdd60c-9a1c-4ef4-ba6b-b911849128f1 | 2024-12-27 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin calcium | LEUCOVORIN CALCIUM | Fresenius Kabi USA, LLC | 4b72d1fd-f389-45d9-b43b-510b45c92263 | 2024-10-14 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Fresenius Kabi USA, LLC | ab691d4e-e0d1-4ba1-9c7a-1cdcfcc3c17c | 2024-10-14 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin calcium | LEUCOVORIN CALCIUM | Fresenius Kabi USA, LLC | d5d4f0fd-7520-43a9-9acc-f7e117e1f6ee | 2024-10-14 | Warnings, Adverse reactions | RPR1R4C0P4 |
| Leucovorin Calcium | LEUCOVORIN CALCIUM | Epic Pharma LLC | 2627a485-05b5-4dab-ac20-dc840e5c469d | 2023-11-08 | Warnings, Adverse reactions | 197863 RPR1R4C0P4 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.